Children’s Specialized Hospital adds Facility with Mediware’s WORx

Children’s Specialized Hospital Opens Facility in New Brunswick, Expanding its License of Mediware’s WORx Medication Management Product

LENEXA, KS, February 6, 2007Mediware Information Systems, Inc., (NASDAQ: MEDW ) announced that Children’s Specialized Hospital in Mountainside, New Jersey, has opened a new facility. To serve the children at this new site, they have chosen to extend their relationship with Mediware by expanding their use of Mediware’s WORx Inpatient Medication Management product. Children’s Specialized Hospital is the largest pediatric rehabilitation hospital in the U.S., and an affiliate member of the Robert Wood Johnson Health System.

PSE&G Children’s Specialized Hospital located in New Brunswick NJ, named after the utility company in recognition of its $5 million gift, will specialize in inpatient care and rehabilitation for children with brain and spinal cord injuries. The current hospital in Mountainside will be renovated to serve outpatient and long-term care patients.

WORx® is an advanced drug therapy management system for all inpatient services that provides comprehensive support for integration, automation, and streamlining the pharmacy workflow. WORx is the pharmacy information management component of Mediware’s Medication Safety suite of products. Other elements of the suite include: MediREC™, MediMAR®, and MediCOE™.

About Mediware

Mediware delivers blood and medication management software systems that encapsulate information supporting patient therapies, reinforce patient safety practices and improve efficiencies to lower costs. Mediware’s customers include prestigious hospitals, clinics, correctional institutions, blood centers and other public and private health care institutions throughout the world. For more information about Mediware products and services, visit our web site at www.mediware.com.

Certain statements in this press release may constitute “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the “Act”) and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company’s Annual Report on Form 10-K for the year ended June 30, 2007, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.